Wound

0
Pipeline Programs
1
Companies
3
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

MolecuLight
MolecuLightON - Toronto
3 programs
MolecuLight PIDN/A1 trial
Point-spectroscopy TrialN/A1 trial
Positive Predictive Value (PPV) of Pseudomonas AeruginosaN/A1 trial
Active Trials
NCT03967405UnknownEst. Mar 2021
NCT05183698UnknownEst. Dec 2022
NCT03290690UnknownEst. Jul 2020

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
MolecuLightPoint-spectroscopy Trial
MolecuLightMolecuLight PID
MolecuLightPositive Predictive Value (PPV) of Pseudomonas Aeruginosa

Clinical Trials (3)

NCT05183698MolecuLightPoint-spectroscopy Trial

Point-spectroscopy Trial

Start: Jan 2022Est. completion: Dec 2022
N/AUnknown
NCT03967405MolecuLightMolecuLight PID

A Prospective Evaluation of Clinical Equivalence Between iX and PID

Start: Aug 2019Est. completion: Mar 2021
N/AUnknown
NCT03290690MolecuLightPositive Predictive Value (PPV) of Pseudomonas Aeruginosa

Positive Predictive Value (PPV) of Pseudomonas Aeruginosa

Start: Aug 2017Est. completion: Jul 2020
N/AUnknown

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 companies competing in this space